Form 8-K - Current report:
SEC Accession No. 0001437749-25-008137
Filing Date
2025-03-18
Accepted
2025-03-18 07:15:30
Documents
15
Period of Report
2025-03-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K eton20250305_8k.htm   iXBRL 8-K 26381
2 EXHIBIT 99.1 ex_786379.htm EX-99.1 308715
  Complete submission text file 0001437749-25-008137.txt   495652

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA eton-20250318.xsd EX-101.SCH 3579
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eton-20250318_def.xml EX-101.DEF 11807
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE eton-20250318_lab.xml EX-101.LAB 15858
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eton-20250318_pre.xml EX-101.PRE 12022
17 EXTRACTED XBRL INSTANCE DOCUMENT eton20250305_8k_htm.xml XML 2982
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

EIN.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38738 | Film No.: 25746487
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)